Cover Story
Models of Transparency
Models of Transparency
Joan K. Heath, Richard White, Kirsten C. Sadler, David Langenau | Apr 1, 2013
Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.
Color from Structure
Color from Structure
Cristina Luiggi | Feb 1, 2013
Researchers are working to understand how often-colorless biological nanostructures give rise to some of the most spectacular technicolor displays in nature.
Games for Science
Games for Science
The Scientist Staff | Jan 1, 2013
Scientists are using video games to tap the collective intelligence of people around the world, while doctors and educators are turning to games to treat and teach.
Fat's Immune Sentinels
Fat's Immune Sentinels
Justin Odegaard and Ajay Chawla | Dec 1, 2012
Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.
Coming to Terms
Coming to Terms
Anna Ajduk and Magdalena Zernicka-Goetz | Nov 1, 2012
New noninvasive methods of selecting the most viable embryo could revolutionize in vitro fertilization.
Lamarck and the Missing Lnc
Kevin V. Morris | Oct 1, 2012
Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.
Celebrating 25 Years of The Scientist
The Scientist Staff | Oct 1, 2011
Our silver anniversary issue celebrates a quarter century of covering major advances in the life sciences—some in fields that didn’t even exist when we first went to press—and looks ahead to future research milestones.
Vaccines
Robin A. Weiss and Peter Hale | Jun 1, 2011
Looking back, looking ahead
Taking Aim at Melanoma
Keith T. Flaherty | Apr 1, 2011
Understanding oncogenesis at the molecular level offers the prospect of tailoring treatments much more precisely for patients with advanced cases of this deadliest of skin cancers.
Epigenetic Changes in Cancer
Manel Esteller | Mar 1, 2011
The study of how covalent marks on DNA and histones are involved in the origin and spread of cancer cells is also leading to new therapeutic strategies.